Adina Popa

486 total citations
36 papers, 377 citations indexed

About

Adina Popa is a scholar working on Psychiatry and Mental health, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Adina Popa has authored 36 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 9 papers in Pharmacology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Adina Popa's work include Blood Pressure and Hypertension Studies (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Treatment of Major Depression (5 papers). Adina Popa is often cited by papers focused on Blood Pressure and Hypertension Studies (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Treatment of Major Depression (5 papers). Adina Popa collaborates with scholars based in Romania, Austria and Canada. Adina Popa's co-authors include Laurian Vlase, Dana Muntean, Sorin E. Leucuţa, Cécilia Cristea, Bogdan Feier, Marius Bojiţă, Mihaela Tertiş, Anca Dana Buzoianu, Maria Adriana Neag and Ana-Maria Gheldiu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Psychiatry and Journal of Clinical Medicine.

In The Last Decade

Adina Popa

31 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adina Popa Romania 13 83 75 69 47 43 36 377
Pierre Voirol Switzerland 13 50 0.6× 59 0.8× 110 1.6× 54 1.1× 53 1.2× 42 537
Surulivelrajan Mallayasamy India 14 42 0.5× 45 0.6× 120 1.7× 97 2.1× 54 1.3× 62 794
Sabariah Noor Harun Malaysia 13 28 0.3× 47 0.6× 29 0.4× 22 0.5× 51 1.2× 58 529
Vijay Khajuria India 11 31 0.4× 65 0.9× 71 1.0× 42 0.9× 9 0.2× 71 529
Lorenzo Villa Zapata United States 14 72 0.9× 27 0.4× 49 0.7× 122 2.6× 14 0.3× 68 509
Arden R. Barry Canada 16 253 3.0× 61 0.8× 33 0.5× 75 1.6× 23 0.5× 89 696
Frank Donath Germany 13 81 1.0× 97 1.3× 62 0.9× 13 0.3× 32 0.7× 33 646
Kurt A. Wargo United States 16 77 0.9× 60 0.8× 141 2.0× 96 2.0× 10 0.2× 36 752
Sally Usdin Yasuda United States 14 155 1.9× 54 0.7× 82 1.2× 63 1.3× 58 1.3× 21 499
Leelavathi D Acharya India 11 32 0.4× 35 0.5× 76 1.1× 68 1.4× 24 0.6× 34 561

Countries citing papers authored by Adina Popa

Since Specialization
Citations

This map shows the geographic impact of Adina Popa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adina Popa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adina Popa more than expected).

Fields of papers citing papers by Adina Popa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adina Popa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adina Popa. The network helps show where Adina Popa may publish in the future.

Co-authorship network of co-authors of Adina Popa

This figure shows the co-authorship network connecting the top 25 collaborators of Adina Popa. A scholar is included among the top collaborators of Adina Popa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adina Popa. Adina Popa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bodolea, Constantin, et al.. (2025). Effectiveness and Safety of Linezolid as Continuous Infusion Versus Intermittent Infusion in Critically Ill Patients: A Pilot Study. SHILAP Revista de lepidopterología. 5(4). 61–61.
2.
Hinterbuchinger, Barbara, et al.. (2025). Participatory research with co-researchers with lived experience of psychosis high risk states. Frontiers in Psychiatry. 16. 1530093–1530093.
3.
4.
Bodolea, Constantin, et al.. (2024). Linezolid Pharmacokinetics in Critically Ill Patients: Continuous Versus Intermittent Infusion. Antibiotics. 13(10). 961–961. 1 indexed citations
5.
Neag, Maria Adriana, Laurian Vlase, Anca Dana Buzoianu, et al.. (2016). Pharmacokinetic interaction between fluvoxamine and lansoprazole in healthy volunteers.. 8(1). 59–64.
6.
Popa, Adina, Maria Adriana Neag, Dana Muntean, et al.. (2016). Evaluation of the Potential Pharmacokinetic Interaction between Atomoxetine and Fluvoxamine in Healthy Volunteers. Pharmacology. 99(1-2). 84–88. 7 indexed citations
7.
Gheldiu, Ana-Maria, Adina Popa, Maria Adriana Neag, et al.. (2016). Assessment of a Potential Pharmacokinetic Interaction between Nebivolol and Bupropion in Healthy Volunteers. Pharmacology. 98(3-4). 190–198. 15 indexed citations
8.
Bojiţă, Marius, et al.. (2016). Potentially inappropriate medications in elderly ambulatory and institutionalized patients: an observational study. BMC Pharmacology and Toxicology. 17(1). 38–38. 24 indexed citations
9.
Popa, Adina, Maria Adriana Neag, Dana Muntean, et al.. (2016). Evaluation of a Potential Metabolism-Mediated Drug-Drug Interaction Between Atomoxetine and Bupropion in Healthy Volunteers. Journal of Pharmacy & Pharmaceutical Sciences. 19(2). 198–198. 21 indexed citations
10.
Neag, Maria Adriana, Dana Muntean, Ioana Corina Bocșan, et al.. (2015). Phenotypic differences in nebivolol metabolism and bioavailability in healthy volunteers. Medicine and Pharmacy Reports. 88(2). 208–213. 16 indexed citations
11.
Dumitraş, Diana E., et al.. (2015). Evaluation of restricted antibiotic use in a hospital in Romania. International Journal of Clinical Pharmacy. 37(3). 452–456. 15 indexed citations
12.
Popa, Adina, Maria Adriana Neag, Dana Muntean, et al.. (2015). THE INFLUENCE OF PAROXETINE ON THE PHARMACOKINETICS OF ATOMOXETINE AND ITS MAIN METABOLITE. Medicine and Pharmacy Reports. 88(4). 513–520. 6 indexed citations
13.
Mallet, Louise, et al.. (2014). Description of a systematic pharmaceutical care approach intended to increase the appropriateness of medication use by elderly patients. Medicine and Pharmacy Reports. 87(2). 119–129. 1 indexed citations
14.
Vlase, Laurian, et al.. (2012). Pharmacokinetic Interaction between Ivabradine and Phenytoin in Healthy Subjects. Clinical Drug Investigation. 32(8). 533–538. 24 indexed citations
15.
Vlase, Laurian, et al.. (2011). Effect of fluvoxamine on the pharmokinetics of zolpidem: A two‐treatment period study in healthy volunteers. Clinical and Experimental Pharmacology and Physiology. 39(1). 9–12. 8 indexed citations
16.
Vlase, Laurian, et al.. (2011). Effect of Fluoxetine on the Pharmacokinetics of Lansoprazole. Clinical Drug Investigation. 31(10). 727–733. 8 indexed citations
17.
Vlase, Laurian, Adina Popa, Dana Muntean, & Sorin E. Leucuţa. (2011). Pharmacokinetics and comparative bioavailability of two fenofibrate capsule formulations in healthy volunteers. Arzneimittelforschung. 60(9). 560–563. 9 indexed citations
18.
Vlase, Laurian, et al.. (2010). Pharmacokinetic Interaction Between Zolpidem and Carbamazepine in Healthy Volunteers. The Journal of Clinical Pharmacology. 51(8). 1233–1236. 19 indexed citations
19.
Vlase, Laurian, et al.. (2010). Pharmacokinetic interaction between fluoxetine and omeprazole in healthy male volunteers: a prospective pilot study. Current Therapeutic Research. 71(6). 360–368. 9 indexed citations
20.
Vlase, Laurian, et al.. (2010). Pharmacokinetic interaction between zolpidem and ciprofloxacin in healthy volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 35(3-4). 83–87. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre Voirol Breakdown of academic impact, for papers by Surulivelrajan Mallayasamy Breakdown of academic impact, for papers by Sabariah Noor Harun Breakdown of academic impact, for papers by Vijay Khajuria Breakdown of academic impact, for papers by Lorenzo Villa Zapata Breakdown of academic impact, for papers by Arden R. Barry Breakdown of academic impact, for papers by Frank Donath Breakdown of academic impact, for papers by Kurt A. Wargo Breakdown of academic impact, for papers by Sally Usdin Yasuda Breakdown of academic impact, for papers by Leelavathi D Acharya
Rankless by CCL
2026